1. Home
  2. ABEO vs PERF Comparison

ABEO vs PERF Comparison

Compare ABEO & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PERF
  • Stock Information
  • Founded
  • ABEO N/A
  • PERF 2015
  • Country
  • ABEO United States
  • PERF Taiwan
  • Employees
  • ABEO N/A
  • PERF N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PERF Computer Software: Prepackaged Software
  • Sector
  • ABEO Health Care
  • PERF Technology
  • Exchange
  • ABEO Nasdaq
  • PERF Nasdaq
  • Market Cap
  • ABEO 243.9M
  • PERF 263.8M
  • IPO Year
  • ABEO 1980
  • PERF N/A
  • Fundamental
  • Price
  • ABEO $5.19
  • PERF $2.80
  • Analyst Decision
  • ABEO Strong Buy
  • PERF Buy
  • Analyst Count
  • ABEO 3
  • PERF 2
  • Target Price
  • ABEO $18.00
  • PERF $4.00
  • AVG Volume (30 Days)
  • ABEO 251.8K
  • PERF 292.8K
  • Earning Date
  • ABEO 11-14-2024
  • PERF 02-26-2025
  • Dividend Yield
  • ABEO N/A
  • PERF N/A
  • EPS Growth
  • ABEO N/A
  • PERF N/A
  • EPS
  • ABEO N/A
  • PERF 0.05
  • Revenue
  • ABEO N/A
  • PERF $58,445,000.00
  • Revenue This Year
  • ABEO N/A
  • PERF $15.76
  • Revenue Next Year
  • ABEO $15,721.96
  • PERF $13.32
  • P/E Ratio
  • ABEO N/A
  • PERF $55.17
  • Revenue Growth
  • ABEO 147.52
  • PERF 15.84
  • 52 Week Low
  • ABEO $3.05
  • PERF $1.70
  • 52 Week High
  • ABEO $9.01
  • PERF $3.77
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 34.35
  • PERF 55.41
  • Support Level
  • ABEO $5.05
  • PERF $2.25
  • Resistance Level
  • ABEO $5.66
  • PERF $2.87
  • Average True Range (ATR)
  • ABEO 0.27
  • PERF 0.42
  • MACD
  • ABEO -0.06
  • PERF -0.02
  • Stochastic Oscillator
  • ABEO 13.21
  • PERF 46.22

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions that are ultra-personalized, interactive and engaging, from online to in-store through beauty mirrors. Geographically, the company has a presence in the United States, France, Japan and Others.

Share on Social Networks: